SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-021112
Filing Date
2017-04-20
Accepted
2017-04-20 06:02:53
Documents
6
Period of Report
2017-06-01
Effectiveness Date
2017-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A v464522_def14a.htm DEF 14A 1271296
2 GRAPHIC pg2logo1_pre14a.jpg GRAPHIC 16750
3 GRAPHIC pg1img1_appendix-b.jpg GRAPHIC 217470
4 GRAPHIC pg2img1_appendix-b.jpg GRAPHIC 251023
5 GRAPHIC proxy_001.jpg GRAPHIC 152945
6 GRAPHIC proxy_002.jpg GRAPHIC 105670
  Complete submission text file 0001144204-17-021112.txt   2297645
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 17771269
SIC: 2836 Biological Products, (No Diagnostic Substances)